COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01822314
Brief Title: Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer (ETNA)

First Submitted : March 25, 2013
First Submitted that Met QC Criteria : March 27, 2013
First Posted : April 2, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : August 7, 2019
Last Update Posted : August 8, 2019